These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11004305)

  • 21. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis.
    Ferrante P; Ramsey A; Bunce C; Lightman S
    Clin Exp Ophthalmol; 2004 Dec; 32(6):563-8. PubMed ID: 15575824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis.
    Gwon A; Mantras C; Gruber L; Cunanan C
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3483-8. PubMed ID: 8258503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.
    Herman DC; Gordon MO; Beiser JA; Chylack LT; Lamping KA; Schein OD; Soltau JB; Kass MA;
    Am J Ophthalmol; 2006 Nov; 142(5):800-10. PubMed ID: 17056362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for steroid response among cataract patients.
    Chang DF; Tan JJ; Tripodis Y
    J Cataract Refract Surg; 2011 Apr; 37(4):675-81. PubMed ID: 21420592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
    Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S
    J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular pressure profile of a child on a systemic corticosteroid.
    Tham CC; Ng JS; Li RT; Chik KW; Lam DS
    Am J Ophthalmol; 2004 Jan; 137(1):198-201. PubMed ID: 14700676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME; O'Halloran H; VanderVeen D; Roarty J; Plager DA; Markwardt K; Gedif K; Lambert SR
    Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Side-effects of triamcinolone in young patients].
    Suárez-Figueroa M; Contreras I; Noval S
    Arch Soc Esp Oftalmol; 2006 Jul; 81(7):405-7. PubMed ID: 16888694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and potential complications of difluprednate use for pediatric uveitis.
    Slabaugh MA; Herlihy E; Ongchin S; van Gelder RN
    Am J Ophthalmol; 2012 May; 153(5):932-8. PubMed ID: 22265149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior subcapsular cataract and inhaled corticosteroid therapy.
    Abuekteish F; Kirkpatrick JN; Russell G
    Thorax; 1995 Jun; 50(6):674-6. PubMed ID: 7638813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205.
    Stewart WC;
    Arch Ophthalmol; 2003 Nov; 121(11):1543-7. PubMed ID: 14609909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Posterior subcapsular cataract in a case of ulcerative colitis treated with corticosteroid enema].
    Patteau F; Bourcier T; Naacke H; Allahdadi H; Borderie V; Laroche L
    J Fr Ophtalmol; 2003 Oct; 26(8):834-6. PubMed ID: 14586226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement.
    Mandell KJ; Clark D; Chu DS; Foster CS; Sheppard J; Brady TC
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):732-739. PubMed ID: 32955967
    [No Abstract]   [Full Text] [Related]  

  • 36. Posterior subcapsular cataracts after topical corticosteroid therapy.
    Gasset AR; Bellows RT
    Ann Ophthalmol; 1974 Dec; 6(12):1263-5. PubMed ID: 4440976
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pressure increase in local corticosteroid administration].
    Hiller H
    Z Arztl Fortbild (Jena); 1969 Oct; 63(19):1038-9. PubMed ID: 5362221
    [No Abstract]   [Full Text] [Related]  

  • 38. Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis.
    Li J; Heinz C; Zurek-Imhoff B; Heiligenhaus A
    J Cataract Refract Surg; 2006 Sep; 32(9):1535-9. PubMed ID: 16931268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease.
    Tripathi RC; Kipp MA; Tripathi BJ; Kirschner BS; Borisuth NS; Shevell SK; Ernest JT
    Lens Eye Toxic Res; 1992; 9(3-4):469-82. PubMed ID: 1301798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid therapy of eye disease. Fifty years later.
    Raizman M
    Arch Ophthalmol; 1996 Aug; 114(8):1000-1. PubMed ID: 8694704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.